| __timestamp | ImmunityBio, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 13673000 |
| Thursday, January 1, 2015 | 11434000 | 14358000 |
| Friday, January 1, 2016 | 26546000 | 12203000 |
| Sunday, January 1, 2017 | 39778000 | 18125000 |
| Monday, January 1, 2018 | 53418000 | 17071000 |
| Tuesday, January 1, 2019 | 111997000 | 20018000 |
| Wednesday, January 1, 2020 | 139507000 | 32788000 |
| Friday, January 1, 2021 | 195958000 | 44966000 |
| Saturday, January 1, 2022 | 248149000 | 311681000 |
| Sunday, January 1, 2023 | 232366000 | 77707000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology and pharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, ImmunityBio, Inc. and Lantheus Holdings, Inc. have demonstrated contrasting strategies in their R&D allocations.
From 2014 to 2023, ImmunityBio, Inc. increased its R&D expenses by an impressive 14,500%, peaking in 2022. This upward trajectory underscores the company's commitment to innovation, with a focus on developing cutting-edge therapies.
Lantheus Holdings, Inc., while initially more conservative, saw a dramatic surge in 2022, with R&D spending skyrocketing by over 600% compared to 2021. This strategic investment highlights a pivotal shift towards enhancing their product pipeline.
Both companies exemplify the dynamic nature of R&D investment, each carving its path in the quest for medical breakthroughs.
Comparing Innovation Spending: Johnson & Johnson and ImmunityBio, Inc.
Research and Development Expenses Breakdown: argenx SE vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Lantheus Holdings, Inc.
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
R&D Insights: How Halozyme Therapeutics, Inc. and ImmunityBio, Inc. Allocate Funds
Research and Development Investment: Lantheus Holdings, Inc. vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Mesoblast Limited
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Perrigo Company plc or ImmunityBio, Inc.: Who Invests More in Innovation?